Smileband health topics

After decades of research, scientists have failed to find any effective treatment for Alzheimer’s disease, and, following futile efforts, last month pharmaceutical giant Pfizer announced it is ending its own dementia research programme. The reason for this lack of progress is beginning to emerge: the scientific idea underpinning the majority of treatments and clinical trials is fundamentally flawed.

Scientists have spent years developing treatments that target a protein called amyloid, which plays a vital role in healthy nerve cell function, but can become corrupted — sticking together to form damaging clumps or plaques, which destroy nerve cells. <!-- Global site tag (gtag.js) - Google Analytics -->

<script async src="https://www.googletagmanager.com/gtag/js?id=UA-109237959-1"></script>

<script>

  window.dataLayer = window.dataLayer || [];

  function gtag(){dataLayer.push(arguments);}

  gtag('js', new Date());

  gtag('config', 'UA-109237959-1');

</script>

<!-- Google tag (gtag.js) -->

<script async src="https://www.googletagmanager.com/gtag/js?id=G-XDGJVZXVQ4"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-XDGJVZXVQ4'); </script>